Two Trump administration cabinet members have announced that their departments are launching a new partnership to collaborate on research and development of psychedelic medicines to treat people struggling with serious mental health conditions.
The Department of Health and Human Services (HHS) and Department of Veterans Affairs (VA) signed a memorandum of understanding, unveiled on Monday, that comes months after President Donald Trump issued an executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics.
“America owes every veteran the best care our nation can provide,” HHS Secretary Robert F. Kennedy, Jr. said in a press release. “We’re not going to wait while promising treatments sit on the sidelines. Thanks to President Trump’s leadership, HHS and the VA are working together to develop safe, FDA-approved innovations and transition them from research into care so veterans can access the treatments they deserve.”
VA Secretary Doug Collins said that “President Trump opened up a world of possibility for treating veterans and others with mental health conditions, and VA is proud to be part of this important work.”
“Today’s MOU ensures effective cooperation with HHS as we try to turn research into life-changing treatment,” he said.
Under the MOU,
Read full article on Marijuana Moment
